Association of P2Y12 Gene Promoter DNA Methylation with the Risk of Clopidogrel Resistance in Coronary Artery Disease Patients

Figure 1

Comparison of P2Y12 methylation levels between cases and controls. P2Y12 CpG1 (cases versus controls (%): 43.31±10.96 versus 44.89±9.26, 𝑃=0.420) and P2Y12 CpG2 (cases versus controls (%): 37.00±7.52 versus 37.32±6.82, 𝑃=0.821).